Placemark Investments’s QIAGEN NV QGENF Stock Holding History

Placemark Investments’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$626K	Sell	26,766 -5,733	-18%	-$134K	0.01%	1076
2014 Q3	$738K	Buy	32,499 +22,090	+212%	+$502K	0.01%	1008
2014 Q2	$256K	Buy	10,409 +79	+0.8%	+$1.94K	﹤0.01%	1465
2014 Q1	$219K	Sell	10,330 -407	-4%	-$8.63K	﹤0.01%	1476
2013 Q4	$254K	Sell	10,737 -81	-0.7%	-$1.92K	﹤0.01%	1429
2013 Q3	$233K	Sell	10,818 -128	-1%	-$2.76K	﹤0.01%	1423
2013 Q2	$219K	Buy	+10,946	New	+$219K	﹤0.01%	1411

Other funds holding QGENF

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $38.1B AUM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Placemark Investments's QGENF Position: Q4 2014 in Review

Placemark Investments reduced its QIAGEN NV (QGENF) stake by 18% in Q4 2014, selling an estimated $134K and leaving 26,766 shares worth $626K. The position accounts for 0.01% of the portfolio, ranked #1076.

Placemark Investments first reported a position in QGENF in Q2 2013 and has held it in 7 quarters since. The position peaked at $738K in Q3 2014. 172 funds tracked by Wall St. Rank hold QGENF as of Q4 2014.

Placemark Investments held 26,766 shares of QIAGEN NV worth $626K as of Q4 2014.
Placemark Investments sold 5,733 QIAGEN NV shares in Q4 2014, an estimated $134K.
QIAGEN NV made up 0.01% of Placemark Investments's portfolio in Q4 2014, its #1076 holding.
Placemark Investments first reported a position in QIAGEN NV in Q2 2013 and has held it in 7 quarters since.
Placemark Investments's QIAGEN NV position peaked at $738K in Q3 2014.
172 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.